NEWS
Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent.
Working together to enhance patient care
We’re partnering to revolutionise patient care by leveraging multiomic insights.
Access leading
multiomic solutions
Multiomic insights are revolutionising the development of diagnostics and precision therapies, offering patients faster and more accurate diagnoses, as well as more targeted and effective treatment options.
We offer access to our novel multiomic solutions through an expanding range of services, designed to meet your research and development needs.
Enchancing biopharma innovation
We are empowering biopharma with cutting-edge multiomic solutions to drive the development and translation of world-leading precision medicines.
Advanced disease insights
Identification of novel multiomic biomarkers
Clinical trial optimisation
Treatment efficacy and response
Collaborating to create the best diagnostics for patients
We are forging strategic collaborations to develop cutting-edge genomics-based diagnostics.
By partnering with both commercial entities and clinical research institutions, we are pioneering the integration of multiomics into advanced genomics-driven diagnostic assays.
In oncology and beyond, collaborate with us to develop diagnostic tests that offer enhanced sensitivity, specificity, and deeper clinical insights.
NEWS
Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent.
Working together to enhance patient care
We’re partnering to revolutionise patient care by leveraging multiomic insights.
Access leading
multiomic solutions
Multiomic insights are revolutionising the development of diagnostics and precision therapies, offering patients faster and more accurate diagnoses, as well as more targeted and effective treatment options.
We offer access to our novel multiomic solutions through an expanding range of services, designed to meet your research and development needs.
Enchancing biopharma innovation
We are empowering biopharma with cutting-edge multiomic solutions to drive the development and translation of world-leading precision medicines.
Advanced disease insights
Identification of novel multiomic biomarkers
Clinical trial optimisation
Treatment efficacy and response
Collaborating to create the best diagnostics for patients
We are forging strategic collaborations to develop cutting-edge genomics-based diagnostics.
By partnering with both commercial entities and clinical research institutions, we are pioneering the integration of multiomics into advanced genomics-driven diagnostic assays.
In oncology and beyond, collaborate with us to develop diagnostic tests that offer enhanced sensitivity, specificity, and deeper clinical insights.
